We bring our talent together

Vall d'Hebron Institute of Oncology

Beating cancer

 

The VHIO has some of the most dynamic cancer research programmes in Spain. Scientists and clinical researchers work together on a purely translational model, addressing the disease in a comprehensive way, to accelerate and advance towards more specialised therapies to combat cancer.

Vall d'Hebron Institut d'Oncologia

Presentation

At the VHIO, doctors and scientists come together in multidisciplinary teams in order to provide improvements in the field of oncological diseases, and translate discoveries into medical benefits. More than 200 researchers and healthcare staff are dedicated to understanding the way cancer works, from biology and genetics to treatment.

Through translational research, knowledge resulting from research can be used to prevent and treat cancer. The symbiosis between VHIO and the hospital, this constant dialogue between patients and research, reduces the gap between laboratory results and patient care.

VHIO activity is divided into four main programmes: preclinical, translational, clinical and core technologies research; all focused on offering cancer patients less aggressive and more personalised treatments. Vall d’Hebron Campus has great potential, providing direct access to its whole range of oncology professionals and possible treatments.

The best professionals dedicated to addressing the many questions that remain unanswered in order to beat the multidimensional, heterogeneous and complex disease that is cancer.

 
Research gropus
Related professionals
Dr. Josep
Tabernero Caturla
Head of Department
Medical Oncology
Sr. Fran
Garcia Morales
Director of Communications, Corporate Strategy and Citizens Advice
Communications Management, Corporate Strategy and Citizens Advice
Director of Communications, Corporate Strategy and Citizens Advice
Communications Management, Corporate Strategy and Citizens Advice
Director of Communications, Corporate Strategy and Citizens Advice
Communications Management, Corporate Strategy and Citizens Advice
Director of Communications, Corporate Strategy and Citizens Advice
Communications Management, Corporate Strategy and Citizens Advice
Dra. Enriqueta
Felip
Head of Section
Medical Oncology
Lead Researcher
Thoracic tumours and head and neck cancer group
Dr. César
Serrano García
Doctor
Medical Oncology
Lead Researcher
Genitourinary, Central Nervous System (CNS) Tumours, Sarcoma and cancer of unknown primary site programme
Dra. Cristina
Saura Manich
Head of Unit
Medical Oncology
Clinical Researcher
Breast cancer and melanoma group
Dr. Joan
Carles Galcerán
Head of Section
Medical Oncology
Lead Researcher
Genitourinary, Central Nervous System (CNS) Tumours, Sarcoma and cancer of unknown primary site programme
Dra. Olivia
Pujol Carreras
Researcher
Oncogenetics group
Dr. Fernando
Ascanio Gosling
Dra. Fiorella
Ruiz-Pace
Research Technician
Oncology data science (ODysSey) group
Dra. Isabel
Cidoncha Muñoz
Head of Unit
Clinical research, Early clinical development of drugs group
Sra. Patricia
García Ortega
Sra. Eugènia
Serramontmany
Pharmacist
Pharmacy
Sra. Cristina
Viaplana
Research Technician
Oncology data science (ODysSey) group

Our figures

10.96

average IF

3,000

patients with molecular prescreening

20

research groups

News and events
See more
Embedded thumbnail for We wish you a Happy New Year and Good Health in 2018!
We wish you a Happy New Year and Good Health in 2018!
We wish you a Happy New Year and Good Health in 2018!
20.12.2017

The patients and staff at Vall d’Hebron wish you a Happy New Year and Good Health in 2018!

Embedded thumbnail for New research building and Campus transformation
New research building and Campus transformation
Josep Tabernero, cap del Servei d'Oncologia Mèdica a Vall d'Hebron
“We’ve never known as much about cancer as we do now”